Bing

SEARCH HISTORY

Small-cap biopharmaceutical company Peregrine Pharmaceuticals (NASDAQ: PPHM) could be sitting in the sweet spot when ... As you can tell, there's significant potential here. But, with the stock trading for just a …
Investopedia · 6/30/2015
Peregrine
Source: Flickr user David Goehring. Peregrine Pharmaceuticals (NASDAQ: PPHM ) The first small cap stock to watch is cancer immunotherapy vaccine developer Peregrine Pharmaceuticals, which is currently sporting …
The Motley Fool · BySean Williams · 6/30/2015
Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) opened at 1.29 on Thursday. Peregrine Pharmaceuticals has a one year low of $1.19 and a one year high of $1.89. The stock has a 50-day moving average of $1.38 and a 200-day moving average of …
Ticker Report · 7/2/2015
More from Bing News
Peregrine Pharmaceuticals (NASDAQ:PPHM) opened at 1.29 on Thursday. Peregrine Pharmaceuticals has a 1-year low of $1.19 and a 1-year high of $1.89. The stock’s 50-day moving average is $1.38 and its 200-day moving average is $1.38. The …
sleekmoney.com · 7/2/2015
NEW YORK (TheStreet) -- Peregrine Pharmaceuticals (PPHM - Get Report) shares are up 2.78% to $1.49 in after-hours trading on Thursday after the company reported its third quarter financial results after the closing bell today. The company reported a net ...
The Street · 3/12/2015
See prospectus for additional details. The high yield of the PPHMP preferred stock issue is especially compelling given the company's strong balance sheet. As of fiscal Q3 ending 1/31/2015, PPHM had a $55 million cash balance and was debt free. There …
Seeking Alpha · 5/28/2015
Peregrine Pharmaceuticals, Inc. (PPHM - Snapshot Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The upside came after the company announced a sponsored research agreement with Memorial Sloan …
ZACKS · 6/1/2015
Peregrine Pharmaceuticals, Inc. ( PPHM) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the …
NASDAQ · 10/16/2014
Equities researchers at Roth Capital set a $5.00 price objective on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) stock in a research report issued on Monday. The firm currently has a a “buy” rating on the stock. Roth Capital’s price target ...
Mideast Times · 4/21/2015
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent …
Yahoo Finance · 1/7/2014